PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/b-catenin signaling pathwa

来源 :第四届晋冀鲁豫肝病论坛暨2016年河南省医学会感染肝病学术年会 | 被引量 : 0次 | 上传用户:sinjorzhang
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background and Objectives: Hepatocellular carcinoma (HCC) is one of most common human malignancies worldwide.Numerous studies have shown that a number of protocadherins functioned as tumor suppressors in human carcinogenesis.But little is known about the function of PCDH20 in HCC.Here we investigate the role of PCDH20 in hepatocarcinogenesis.Methods: The expression variant of PCDH20 in HCC cell lines as well as in HCC tissues and paired non-tumor tissues was verified by real-time quantitative RT-PCR and western blot.The DNA methylation status of PCDH20 promoter region was quantitative analyzed by Hha-I digestion and consequent real-time PCR.Finally,the function of PCDH20 on HCC tumor cells was studied by MTT assay,flow cytometry,wound-healing and transwell assays,soft agar assay,as well as tumorigenicity assays using nude mice.Results: We first identified that PCDH20 expression was silenced in 6 of 7 HCC cell lines and down-regulated in about 48% (51/107) primary HCC tissues.The lower expression of PCDH20 in tumor tissues was statistically significant,when compared to that in their paired non-tumor tissues (p<0.001),such lower expression in tumor tissues was much more common in younger patients group (aged <50 years) compared with the old group (≥ 50 years) (60% vs.33%,p=0.0303).Moreover,both in vitro and in vivo experiments demonstrated that ectopic expression of PCDH20 in silenced HCC cells significantly suppressed cell proliferation,migration and tumorigenicity.Moreover,we prove for the first time that PCDH20 could antagonize Wnt/β-catenin signaling pathway,via suppressing Akt and Erk activities and promoting GSK-3 β signaling activities.However,PCDH20 gene deletion and/or promoter hypermethylation attributed expression down-regulation were only observed in a small fraction of tumor specimens.Conclusions: Our data here strongly suggested that through antagonizing the Wnt/β-catenin signaling pathway,PCDH20 may act as a candidate tumor suppressor in HCC.
其他文献
会议
目的:探讨失代偿期乙肝肝硬化行阿德福韦酯联合拉米夫定治疗的效果.方法:资料选取我院2010年10月-2014年10月诊治的112例失代偿期乙肝肝硬化患者,按照随机数字表法分研究组与对照组,研究组行阿德福韦酯联合拉米夫定治疗,对照组行拉米夫定治疗,对比两组血清学指标及不良反应发生率.结果:经治疗研究组HBV-DNA阴转率53.57%、HBeAg阴转率37.50%和HBeAg/抗-HBeAg血清转换率
Hepatic macrophages are the largest nonparenchymal cells group in liver.Recent research have found that hepatic macrophages had different functions in different stages of liver fibrosis in different a
会议
目的 抗线粒体抗体阴性的原发性胆汁性肝硬化(AMA-PBC)是一种少见的自身免疫性肝病,临床上常被误诊或漏诊.本研究比较了AMATBC与抗线粒体抗体阳性的原发性胆汁性肝硬化(AMA+PBC)、自身免疫性肝炎(AIH)的临床生化和病理学特点,旨在分析三种自身免疫性肝病的异同,并寻找有助于诊断AMA-PBC的血清学标志物.方法 回顾性分析我院2005年1月至2013年5月收治的23例AMA-PBC、1
目的 制备一个稳定表达新型荧光素酶的重组乙型肝炎病毒细胞系.方法 构建具有潮霉素(Hyg)抗性的载体质粒pTRE-HBV-S-Nluc,具有杀稻瘟菌素(Bsd)抗性的HBV辅助质粒pcDNA31 (-)Bsd-CH3142与载体质粒共转染HepG2TA2-7细胞[12],经新霉素(G418)、Bsd和Hyg共筛选,获得细胞克隆,进行一系列检测.结果 挑选48个细胞克隆,经检测,最终筛选出6个细胞株
目的 丙型肝炎病毒(HCV)感染是导致慢性肝炎和肝细胞癌的主要原因,而且疾病进展和治疗效果与HCV基因型有较强的相关性.本研究现报道一种准确、简便、廉价的基因基因分型技术,即利用反转录环介导等温扩增(RT-LAMP)对HCV 1b和2a两种在中国常见的基因型进行扩增,该技术有利于在医疗设备匮乏的地区推广应用.方法 首先,根据HCV 5UTR保守序列对1b和2a基因型分别设计RT-LAMP引物.然后
目的:随机安慰剂对照研究中药“疏肝健脾散”对非酒精性脂肪肝患者的临床疗效.方法:将2014年5月至2016年1月在解放军251医院门诊及住院的非酒精性脂肪肝患者80例,按照随机数字表法分为试验组40例,对照组40例.试验组给予疏肝健脾散颗粒剂口服,对照组给予安慰剂口服,疗程为10周.记录两组干预前后两组患者的主要中医症状积分、症状总积分、腹部CT的肝/脾CT比值.肝功能指标、生活质量量表.结果:试
目的:予布拉氏酵母菌散剂对非酒精性脂肪性肝病(NAFLD)的小鼠模型进行干预,初步探讨布拉氏酵母菌疗效及可能的作用机制.方法:建立西方饮食的NAFLD小鼠动物模型,将6-8周龄的C57BL/6雄性小鼠随机分为正常对照组和西方饮食组.造模成功后将西方饮食组随机分为布拉氏酵母菌灌胃组(TB)和灌胃对照组(TD).测定小鼠体重、肝脏湿重;检测血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、甘油三酯(TG
Objective: To investigate the effect of macrophages depletion on CCL4-induced acute liver injury and liver fibrosis recovery in mice.Method: Acute liver injury model were established in BALB/c mice.Ma